Ali Khademhosseini is the Director and CEO of the Terasaki Institute and former Professor at the University of California-Los Angeles where he held a multi-departmental professorship in Bioengineering, Radiology, Chemical, and Biomolecular Engineering and the Director of Center for Minimally Invasive Therapeutics. Read More
Researchers have developed a contact lens that can catch and identify exosomes, nanometer-sized vesicles prevalent in human fluids that have the potential to be diagnostic cancer biomarkers. ...
A new study by The Pennsylvania State University and the Terasaki Institute for Biomedical Innovation (TIBI), has devised a method to decrease the side effects of cancer drugs. ...